Back to KNSA
D. E. Shaw & Co., Inc. KNSA Position History
Kiniksa Pharmaceuticals International, plc
Quarters held
24
Latest value
$10.7M
Q2 2026
Peak value
$43.6M
First seen
Q2 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2022 | $416K |
| Q3 2022 | $1.4M |
| Q4 2022 | $3.6M |
| Q1 2023 | $2.6M |
| Q2 2023 | $3.4M |
| Q3 2023 | $5.5M |
| Q4 2023 | $5.3M |
| Q1 2024 | $4.4M |
| Q2 2024 | $3.2M |
| Q3 2024 | $8M |
| Q4 2024 | $6.1M |
| Q4 2024 | $240K |
| Q1 2025 | $7.2M |
| Q1 2025 | $1.6M |
| Q2 2025 | $17.9M |
| Q2 2025 | $4M |
| Q3 2025 | $37.3M |
| Q3 2025 | $6.8M |
| Q4 2025 | $43.6M |
| Q4 2025 | $7.6M |
| Q1 2026 | $37.7M |
| Q1 2026 | $8.5M |
| Q2 2026 | $25.7M |
| Q2 2026 | $10.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $10.7M | 167.3K | — | — |
| Q2 2026 | $25.7M | 402.5K | — | — |
| Q1 2026 | $8.5M | 176.8K | — | — |
| Q1 2026 | $37.7M | 782.4K | — | — |
| Q4 2025 | $7.6M | 184.2K | — | — |
| Q4 2025 | $43.6M | 1.06M | — | — |
| Q3 2025 | $6.8M | 174.4K | — | — |
| Q3 2025 | $37.3M | 959.8K | — | — |
| Q2 2025 | $4M | 145.2K | — | — |
| Q2 2025 | $17.9M | 646.1K | — | — |
| Q1 2025 | $1.6M | 74.3K | — | — |
| Q1 2025 | $7.2M | 323.5K | — | — |
| Q4 2024 | $240K | 12.1K | — | — |
| Q4 2024 | $6.1M | 307.9K | — | — |
| Q3 2024 | $8M | 321.0K | — | — |
| Q2 2024 | $3.2M | 169.6K | — | — |
| Q1 2024 | $4.4M | 221.9K | — | — |
| Q4 2023 | $5.3M | 304.6K | — | — |
| Q3 2023 | $5.5M | 317.5K | — | — |
| Q2 2023 | $3.4M | 238.6K | — | — |
| Q1 2023 | $2.6M | 239.8K | — | — |
| Q4 2022 | $3.6M | 237.4K | — | — |
| Q3 2022 | $1.4M | 112.2K | — | — |
| Q2 2022 | $416K | 42.9K | — | — |
Other funds holding KNSA
$125.8M
$116.7M
$85.8M
$73.1M